Not applicableUnknownNCT05864599
What this trial is testing
External Validation of Uromonitor as a Biomarker for Optimization of NMIBC Management by the CUETO Group
Who this might be right for
Non-muscle-invasive Bladder Cancer
Pharmalink 600
Showing 20 of 0 results